Forebyggende behandling av nyreskade ved diabetes
Hovedmålet med diabetesbehandlingen er å forebygge organskader, deriblant nyreskade. Dersom det påvises små mengder albumin i urinen, som er et tegn på begynnende nyreskade, er målet å forhindre forverring og utvikling av alvorlig nyreskade.
Annonse
Grunnlaget for forebygging av diabetisk nefropati er behandling av kjente risikofaktorer som høyt blodsukker, høyt blodtrykk, høyt kolesterol og røyking. Ved overvekt er vektreduksjon også nyttig.
Behandlingen av blodsukkeret har som mål å holde langtidsblodsukkeret (HbA1c) omkring 7%. Behandlingen av blodtrykket har som mål å få blodtrykket ned til 135/85 mmHg.
Det er også viktig å forhindre at du får urinveisinfeksjoner, og at du ikke bruker medisiner som kan skade nyrene.
Gjennom slik forebyggende behandling hindres utviklingen av nyreskade. Det reduserer også risikoen for hjerte- og karsykdommer hos pasienter med type 1- og 2-diabetes.
Dette dokumentet er basert på det profesjonelle dokumentet Diabetisk nefropati . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Helsedirektoratet. Nasjonal faglig retningslinje for diabetes. Oslo; Helsedirektoratet, sist faglig oppdatert desember 2018. helsedirektoratet.no
- Centers for Disease Control and Prevention National diabetes fact sheet, 2011 Atlanta, Ga.: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
- Valmadrid CT, Klein R, Moss SE, Klein BE: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100. PubMed
- Persson F, Rossing P. Nyresygdom ved type 2-diabetes. Ugeskr Læger 2012; 174: 2150. Ugeskrift for Læger
- Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH: Predictors of the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004; 328: 1105-8. British Medical Journal
- Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225-32. PubMed
- Caramori ML, Fioretto P, Mauer M: The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000; 49: 1399-1408. PubMed
- Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M: Cellular basis of diabetic nephropathy. 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51: 506-13. PubMed
- Solini A, Dalla Vestra M, Saller A, Nosadini R, Crepaldi G, Fioretto P: The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002; 51: 251-5. PubMed
- Rudberg S, Rasmussen LM, Bangstad HJ, Osterby R: Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. Diabetes Care 2000; 23: 544-8. PubMed
- Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9. British Medical Journal
- The Microalbuminuria Collaborative Study Group: Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: a seven-year prospective study. Diabet Med 1999; 16: 918-25. PubMed
- Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12. British Medical Journal
- The Diabetes Control and Complications Trial Research: Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Group. Diabetes 1997; 46: 1829-39. PubMed
- Chaturvedi N, Fuller JH, Taskinen MR: Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care 2001; 24: 2071-7. PubMed
- Appel GB, Radhakrishnan J, Avram MM, DeFronzo RA, Escobar-Jimenez F, Campos MM, Burgess E, Hille DA, Dickson TZ, Shahinfar S, Brenner BM: Analysis of metabolic parameters as predictors of risk in the RENAAL study. Diabetes Care 2003; 26: 1402-7. PubMed
- Hovind P, Rossing P, Tarnow L, Parving HH: Smoking and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 2003; 26: 911-6. PubMed
- Mollsten AV, Dahlquist GG, Stattin EL, Rudberg S: Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients. Diabetes Care 2001; 24: 805-10. PubMed
- Murussi M, Baglio P, Gross JL, Silveiro SP: Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study. Diabetes Care 2002; 25: 1101-3. PubMed
- Stevens LA, Schmid CH, Greene T, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2 Am J Kidney Dis 2010;56: 486-95 10.1053/j.ajkd.2010.03.026
- MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G: Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004; 27: 195-200. PubMed
- Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-47. Annals of Internal Medicine
- Nosadini R, Velussi M, Brocco E, et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 2000; 49: 476-84. PubMed
- Wong TY, Choi PC, Szeto CC, To KF, Tang NL, Chan AW, Li PK, Lai FM: Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies. Diabetes Care 2002; 25: 900-5. PubMed
- Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003; 348: 2285-93. New England Journal of Medicine